Xtx Topco LTD Checkpoint Therapeutics, Inc. Transaction History

Xtx Topco LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.5 - $3.53 $40,537 - $57,238	-16,215 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.36 - $3.2 $10,327 - $14,003	4,376 Added 36.96%	16,215 $48,000
Q1 2021 May 14, 2021	BUY	$2.6 - $4.16 $30,781 - $49,250	11,839 New	11,839 $37,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $184M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.